article · International Journal of Nanomedicine

<p>Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma</p>

Mahmoud M. A. Elsayed
Mahmoud Mostafa
Montaser Sh. A. Shaykoon
Hatem A. Sarhan
Eman Alaaeldin
Shady Allam
Ahmed Hamed
Bakheet Elsadek

201964 citationsOpen accessKafr el-Sheikh University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Our results firmly suggest the distinctive cancer-suppressive nature of CNTs-SFN-MCs, both against HepG2 cells in vitro and in a DENA-induced HCC rat model in vivo, with a preferential superiority over conventional sorafenib.

Research topics

Nanoparticle-Based Drug Delivery
Graphene and Nanomaterials Applications
Nanoplatforms for cancer theranostics

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2147/ijn.s223920

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.